Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Precise Research Centers
1974
mi
from 98109
Flowood, MS
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Precise Research Centers
1974
mi
from 98109
Flowood, MS
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Heartland Pharma Developments
1151
mi
from 98109
North Platte, NE
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Heartland Pharma Developments
1151
mi
from 98109
North Platte, NE
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Creighton University
1365
mi
from 98109
Omaha, NE
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Creighton University
1365
mi
from 98109
Omaha, NE
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Center for Psychiatry and Behavioral Medicine, Incorporated
873
mi
from 98109
Las Vegas, NV
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Center for Psychiatry and Behavioral Medicine, Incorporated
873
mi
from 98109
Las Vegas, NV
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Nina F. Wimpie, MD Pediatrics
2019
mi
from 98109
Middleburg Heights, OH
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Nina F. Wimpie, MD Pediatrics
2019
mi
from 98109
Middleburg Heights, OH
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
North Star Medical Research, LLC
2020
mi
from 98109
Middleburg Heights, OH
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
North Star Medical Research, LLC
2020
mi
from 98109
Middleburg Heights, OH
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
IPS Research Company
1522
mi
from 98109
Oklahoma City, OK
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
IPS Research Company
1522
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Summit Research Network (Oregon), Incorporated
147
mi
from 98109
Portland, OR
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Summit Research Network (Oregon), Incorporated
147
mi
from 98109
Portland, OR
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Clinical NeuroScience Solutions, Inc.
1876
mi
from 98109
Memphis, TN
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Clinical NeuroScience Solutions, Inc.
1876
mi
from 98109
Memphis, TN
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Focus and Balance, LLC
1779
mi
from 98109
San Antonio, TX
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Focus and Balance, LLC
1779
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Northwest Clinical Research Center
9
mi
from 98109
Bellevue, WA
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Northwest Clinical Research Center
9
mi
from 98109
Bellevue, WA
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Summit Research Network (Seattle) LLC
1
mi
from 98109
Seattle, WA
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Summit Research Network (Seattle) LLC
1
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
The Rogers Center for Research & Training, Inc.
1682
mi
from 98109
Milwaukee, WI
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
The Rogers Center for Research & Training, Inc.
1682
mi
from 98109
Milwaukee, WI
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
ATP Clinical Research, Inc. 1
991
mi
from 98109
Costa Mesa, CA
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
ATP Clinical Research, Inc. 1
991
mi
from 98109
Costa Mesa, CA
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Hospital Medical Center (New)
1966
mi
from 98109
Cincinnati, OH
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center (New)
1966
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Cutting Edge Research Group
1518
mi
from 98109
Oklahoma City, OK
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Cutting Edge Research Group
1518
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Paradigm Research Professionals, Llc
1523
mi
from 98109
Oklahoma City, OK
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Paradigm Research Professionals, Llc
1523
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Hospital Aranda de la Parra, S.A. de C.V.
2162
mi
from 98109
Leon,
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Hospital Aranda de la Parra, S.A. de C.V.
2162
mi
from 98109
Leon,
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Midwest Research Group
1696
mi
from 98109
Saint Charles, MO
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Midwest Research Group
1696
mi
from 98109
Saint Charles, MO
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
St. Charles Psychiatric Associates - Midwest Research Group
1700
mi
from 98109
Saint Charles, MO
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
St. Charles Psychiatric Associates - Midwest Research Group
1700
mi
from 98109
Saint Charles, MO
Click here to add this to my saved trials
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated:  12/31/1969
Grayline Clinical Drug Trials
1555
mi
from 98109
Wichita Falls, TX
A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLUOXETINE-REFERENCED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF DESVENLAFAXINE SUCCINATE SUSTAINED RELEASE (DVS SR) IN THE TREATMENT OF CHILDREN AND ADOLESCENT OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
Status: Enrolling
Updated: 12/31/1969
Grayline Clinical Drug Trials
1555
mi
from 98109
Wichita Falls, TX
Click here to add this to my saved trials
The Treatment of Depression With Botulinum Type A Toxin
The Treatment of Depression With Botulinum Type A Toxin (Botox): A Randomized, Double Blind, Crossover Study
Status: Enrolling
Updated:  12/31/1969
Seton Mind Institute: Medical Park Tower
1770
mi
from 98109
Austin, TX
The Treatment of Depression With Botulinum Type A Toxin
The Treatment of Depression With Botulinum Type A Toxin (Botox): A Randomized, Double Blind, Crossover Study
Status: Enrolling
Updated: 12/31/1969
Seton Mind Institute: Medical Park Tower
1770
mi
from 98109
Austin, TX
Click here to add this to my saved trials
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care (EMBARC) for Depression
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital Boston
2485
mi
from 98109
Boston, MA
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care (EMBARC) for Depression
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital Boston
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care (EMBARC) for Depression
Status: Enrolling
Updated:  12/31/1969
University of Michigan at Ann Arbor
1903
mi
from 98109
Ann Arbor, MI
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care (EMBARC) for Depression
Status: Enrolling
Updated: 12/31/1969
University of Michigan at Ann Arbor
1903
mi
from 98109
Ann Arbor, MI
Click here to add this to my saved trials
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care (EMBARC) for Depression
Status: Enrolling
Updated:  12/31/1969
UT Southwestern Medical Center at Dallas
1682
mi
from 98109
Dallas, TX
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care (EMBARC) for Depression
Status: Enrolling
Updated: 12/31/1969
UT Southwestern Medical Center at Dallas
1682
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care (EMBARC) for Depression
Status: Enrolling
Updated:  12/31/1969
Columbia Univerisity New York City
2262
mi
from 98109
New York, NY
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression
Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care (EMBARC) for Depression
Status: Enrolling
Updated: 12/31/1969
Columbia Univerisity New York City
2262
mi
from 98109
New York, NY
Click here to add this to my saved trials
Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer
Impact of Genomics and Exposures on Disparities in Breast Cancer Radiosensitivity
Status: Enrolling
Updated:  12/31/1969
Wake Forest University Comprehensive Cancer Center
2274
mi
from 98109
Winston-Salem, NC
Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer
Impact of Genomics and Exposures on Disparities in Breast Cancer Radiosensitivity
Status: Enrolling
Updated: 12/31/1969
Wake Forest University Comprehensive Cancer Center
2274
mi
from 98109
Winston-Salem, NC
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Tuscaloosa VA Medical Center, Tuscaloosa, AL
2058
mi
from 98109
Tuscaloosa, AL
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Tuscaloosa VA Medical Center, Tuscaloosa, AL
2058
mi
from 98109
Tuscaloosa, AL
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Phoenix VA Health Care System, Phoenix, AZ
mi
from 98109
Phoenix, AZ
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Phoenix VA Health Care System, Phoenix, AZ
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Southern Arizona VA Health Care System, Tucson
1213
mi
from 98109
Tucson, AZ
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Southern Arizona VA Health Care System, Tucson
1213
mi
from 98109
Tucson, AZ
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
VA Loma Linda Healthcare System, Loma Linda, CA
943
mi
from 98109
Loma Linda, CA
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
VA Loma Linda Healthcare System, Loma Linda, CA
943
mi
from 98109
Loma Linda, CA
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
VA Long Beach Healthcare System, Long Beach, CA
982
mi
from 98109
Long Beach, CA
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
VA Long Beach Healthcare System, Long Beach, CA
982
mi
from 98109
Long Beach, CA
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
VA Palo Alto Health Care System, Palo Alto, CA
707
mi
from 98109
Palo Alto, CA
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
VA Palo Alto Health Care System, Palo Alto, CA
707
mi
from 98109
Palo Alto, CA
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
VA San Diego Healthcare System, San Diego, CA
1065
mi
from 98109
San Diego, CA
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
VA San Diego Healthcare System, San Diego, CA
1065
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
San Francisco VA Medical Center, San Francisco, CA
680
mi
from 98109
San Francisco, CA
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
San Francisco VA Medical Center, San Francisco, CA
680
mi
from 98109
San Francisco, CA
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
VA Eastern Colorado Health Care System, Denver, CO
1020
mi
from 98109
Denver, CO
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
VA Eastern Colorado Health Care System, Denver, CO
1020
mi
from 98109
Denver, CO
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Washington DC VA Medical Center, Washington, DC
2322
mi
from 98109
Washington,
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Washington DC VA Medical Center, Washington, DC
2322
mi
from 98109
Washington,
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Miami VA Healthcare System, Miami, FL
2729
mi
from 98109
Miami, FL
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Miami VA Healthcare System, Miami, FL
2729
mi
from 98109
Miami, FL
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
James A. Haley Veterans' Hospital, Tampa, FL
2522
mi
from 98109
Tampa, FL
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
James A. Haley Veterans' Hospital, Tampa, FL
2522
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Atlanta VA Medical and Rehab Center, Decatur, GA
2182
mi
from 98109
Decatur, GA
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Atlanta VA Medical and Rehab Center, Decatur, GA
2182
mi
from 98109
Decatur, GA
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Edward Hines Jr. VA Hospital, Hines, IL
1724
mi
from 98109
Hines, IL
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Edward Hines Jr. VA Hospital, Hines, IL
1724
mi
from 98109
Hines, IL
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Richard L. Roudebush VA Medical Center, Indianapolis, IN
1867
mi
from 98109
Indianapolis, IN
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Richard L. Roudebush VA Medical Center, Indianapolis, IN
1867
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
2328
mi
from 98109
Baltimore, MD
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
2328
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Minneapolis VA Health Care System, Minneapolis, MN
1394
mi
from 98109
Minneapolis, MN
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Minneapolis VA Health Care System, Minneapolis, MN
1394
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Kansas City VA Medical Center, Kansas City, MO
1506
mi
from 98109
Kansas City, MO
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Kansas City VA Medical Center, Kansas City, MO
1506
mi
from 98109
Kansas City, MO
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE
1359
mi
from 98109
Omaha, NE
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE
1359
mi
from 98109
Omaha, NE
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
New Mexico VA Health Care System, Albuquerque, NM
1184
mi
from 98109
Albuquerque, NM
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
New Mexico VA Health Care System, Albuquerque, NM
1184
mi
from 98109
Albuquerque, NM
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Asheville VA Medical Center, Asheville, NC
2190
mi
from 98109
Asheville, NC
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Asheville VA Medical Center, Asheville, NC
2190
mi
from 98109
Asheville, NC
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC
2281
mi
from 98109
Salisbury, NC
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC
2281
mi
from 98109
Salisbury, NC
Click here to add this to my saved trials
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated:  12/31/1969
Cincinnati VA Medical Center, Cincinnati, OH
1965
mi
from 98109
Cincinnati, OH
VA Augmentation and Switching Treatments for Improving Depression Outcomes
CSP #576 - VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)
Status: Enrolling
Updated: 12/31/1969
Cincinnati VA Medical Center, Cincinnati, OH
1965
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials